Heymann, DL; (2014) Ebola: learn from the past. Nature, 514 (7522). pp. 299-300. ISSN 0028-0836 DOI: https://doi.org/10.1038/514299a Full text not available from this repository.

Shah, A; Diggens, N; Stiller, C; Richards, S; Stevens, MCG; Murphy, MFG; (2014) Recruitment of childhood leukaemia patients to clinical trials in Great Britain during 1980-2007: variation by birth weight, congenital malformation, socioeconomic status and ethnicity. Archives of disease in childhood, 99 (5). pp. 407-412. ISSN 0003-9888 DOI: https://doi.org/10.1136/archdischild-2012-303268 Full text not available from this repository.

Asiki, G; Abaasa, A; Ruzagira, E; Kibengo, F; Bahemuka, U; Mulondo, J; Seeley, J; Bekker, LG; Delany, S; Kaleebu, P; +1 more... Kamali, A; (2013) Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine, 31 (44). pp. 5055-5061. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2013.08.080 Full text not available from this repository.

Rottingen, John-, Arne; Regmi, Sadie; Eide, Mari; Young, AlisonJ; Viergever, RoderikF; Ardal, Christine; Guzman, Javier; Edwards, Danny; Matlin, StephenA; Terry, RobertF; (2013) Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory? Lancet, 382 (9900). pp. 1286-1307. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(13)61046-6 Full text not available from this repository.

Zannad, F; Stough, WG; McMurray, JJV; Remme, WJ; Pitt, B; Borer, JS; Geller, NL; Pocock, SJ; (2012) When to Stop a Clinical Trial Early for Benefit: Lessons Learned and Future Approaches. Circulation Heart failure, 5 (2). pp. 294-302. ISSN 1941-3289 DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.111.965707 Full text not available from this repository.

Hawkins, N; Richardson, G; Sutton, AJ; Cooper, NJ; Griffiths, C; Rogers, A; Bower, P; (2011) Surrogates, meta-analysis and cost-effectiveness modelling: a combined analytic approach. Health economics, 756. pp. 742-756. ISSN 1057-9230 DOI: https://doi.org/10.1002/hec.1741 Full text not available from this repository.

Viergever, RF; Ghersi, D; (2011) The ClinicalTrials.gov Results Database. The New England journal of medicine, 364 (22). 2169-70; author reply 2170. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMc1103910#SA4

Farrell, B; Kenyon, S; Shakur, H; (2010) Managing clinical trials. Trials, 11. ISSN 1745-6215 DOI: https://doi.org/10.1186/1745-6215-11-78

Hawkins, N; Scott, DA; (2010) Cost-effectiveness analysis: discount the placebo at your peril. Medical decision making, 30. pp. 536-43. ISSN 0272-989X DOI: https://doi.org/10.1177/0272989X10362106 Full text not available from this repository.

White, MT; Griffin, JT; Drakeley, CJ; Ghani, AC; (2010) Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. Malaria journal, 9. ISSN 1475-2875 DOI: https://doi.org/10.1186/1475-2875-9-82

Goldacre, B; (2009) Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ (Clinical research ed), 339. b4949. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.b4949

Moorthy, VS; Reed, Z; Smith, PG; (2009) Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review. Malaria journal, 8. p. 23. ISSN 1475-2875 DOI: https://doi.org/10.1186/1475-2875-8-23

Moorthy, VS; Reed, Z; Smith, PG; (2009) MALVAC 2008: Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials-Scientific, regulatory and public health perspectives. Vaccine, 27 (5). pp. 624-628. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2008.11.034 Full text not available from this repository.

Bhutta, ZA; Ali, S; Cousens, S; Ali, TM; Haider, BA; Rizvi, A; Okong, P; Bhutta, SZ; Black, RE; (2008) Alma-Ata: Rebirth and revision 6 - Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make? Lancet, 372 (9642). pp. 972-989. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(08)61407-5 Full text not available from this repository.

Hann, A; Peckham, S; (2008) To vaccinate or to screen - is that the question? The International journal of health planning and management, 23 (1). pp. 69-78. ISSN 0749-6753 DOI: https://doi.org/10.1002/hpm.918 Full text not available from this repository.

Pocock, SJ; Lubsen, J; (2008) More on subgroup analyses in clinical trials. The New England journal of medicine, 358 (19). 2076; author reply 2076-7. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMc0800616

Cheung, YB; (2007) A modified least-squares regression approach to the estimation of risk difference. American journal of epidemiology, 166 (11). pp. 1337-1344. ISSN 0002-9262 DOI: https://doi.org/10.1093/aje/kwm223 Full text not available from this repository.

Wilby, J; Kainth, A; Hawkins, N; Epstein, D; McIntosh, H; McDaid, C; Mason, A; Golder, S; O'Meara, S; Sculpher, M; +2 more... Drummond, M; Forbes, C; (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 9. 1-157, iii-iv. ISSN 1366-5278 DOI: 01-50-01 [pii]

Audige, L; Bhandari, M; Griffin, D; Middleton, P; Reeves, BC; (2004) Systematic reviews of nonrandomized clinical studies in the orthopaedic literature. Clinical orthopaedics and related research (427). pp. 249-257. ISSN 0009-921X DOI: https://doi.org/10.1097/01.blo.0000137558.97346.fb Full text not available from this repository.

Klausner, RD; Fauci, AS; Corey, L; Nabel, GJ; Gayle, H; Berkley, S; Haynes, BF; Baltimore, D; Collins, C; Douglas, RG; +14 more... Esparza, J; Francis, DP; Ganguly, NK; Gerberding, JL; Johnston, MI; Kazatchkine, MD; McMichael, AJ; Makgoba, MW; Pantaleo, G; Piot, P; Shao, Y; Tramont, E; Varmus, H; Wasserheit, JN; (2003) Medicine. The need for a global HIV vaccine enterprise. Science (New York, NY), 300 (5628). pp. 2036-9. ISSN 0036-8075 DOI: https://doi.org/10.1126/science.1086916 Full text not available from this repository.

Toni, D; Gallo, V; Falcou, A; Argentino, C; Fieschi, C; (2001) Treatment of cerebrovascular diseases: state of the art and perspectives. Journal of cardiovascular pharmacology, 38 Sup. S83-6. ISSN 0160-2446 DOI: https://doi.org/10.1097/00005344-200111002-00020 Full text not available from this repository.